BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 15645198)

  • 1. Cellular prion protein neuroprotective function: implications in prion diseases.
    Roucou X; LeBlanc AC
    J Mol Med (Berl); 2005 Jan; 83(1):3-11. PubMed ID: 15645198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prion's elusive reason for being.
    Aguzzi A; Baumann F; Bremer J
    Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant metal binding by prion protein in human prion disease.
    Wong BS; Chen SG; Colucci M; Xie Z; Pan T; Liu T; Li R; Gambetti P; Sy MS; Brown DR
    J Neurochem; 2001 Sep; 78(6):1400-8. PubMed ID: 11579148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein misfolding cyclic amplification induces the conversion of recombinant prion protein to PrP oligomers causing neuronal apoptosis.
    Yuan Z; Yang L; Chen B; Zhu T; Hassan MF; Yin X; Zhou X; Zhao D
    J Neurochem; 2015 Jun; 133(5):722-9. PubMed ID: 25810062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
    Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Pillot T
    Mol Cell Neurosci; 2004 Jan; 25(1):95-102. PubMed ID: 14962743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective functions of prion protein.
    Roucou X; Gains M; LeBlanc AC
    J Neurosci Res; 2004 Jan; 75(2):153-161. PubMed ID: 14705136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo neurotoxicity of prion protein oligomers.
    Simoneau S; Rezaei H; Salès N; Kaiser-Schulz G; Lefebvre-Roque M; Vidal C; Fournier JG; Comte J; Wopfner F; Grosclaude J; Schätzl H; Lasmézas CI
    PLoS Pathog; 2007 Aug; 3(8):e125. PubMed ID: 17784787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases.
    Choi CJ; Kanthasamy A; Anantharam V; Kanthasamy AG
    Neurotoxicology; 2006 Sep; 27(5):777-87. PubMed ID: 16860868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections.
    Watts JC; Drisaldi B; Ng V; Yang J; Strome B; Horne P; Sy MS; Yoong L; Young R; Mastrangelo P; Bergeron C; Fraser PE; Carlson GA; Mount HT; Schmitt-Ulms G; Westaway D
    EMBO J; 2007 Sep; 26(17):4038-50. PubMed ID: 17703189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prion Concept and Synthetic Prions.
    Legname G; Moda F
    Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
    Faburay B; Tark D; Kanthasamy AG; Richt JA
    Prion; 2014; 8(6):393-403. PubMed ID: 25495764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of trace elements in the pathogenesis of prion diseases.
    Mizuno D; Koyama H; Ohkawara S; Sadakane Y; Kawahara M
    Curr Pharm Biotechnol; 2014; 15(11):1049-57. PubMed ID: 25373386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Prion Selection and Adaptation.
    Bistaffa E; Moda F; Virgilio T; Campagnani I; De Luca CMG; Rossi M; Salzano G; Giaccone G; Tagliavini F; Legname G
    Mol Neurobiol; 2019 Apr; 56(4):2978-2989. PubMed ID: 30074230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational conversion of prion protein in prion diseases.
    Zhou Z; Xiao G
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first non-prion pathogen identified: neurotropic influenza virus.
    Sakaguchi S; Hara H
    Prion; 2022 Dec; 16(1):1-6. PubMed ID: 34978525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras.
    Kupfer L; Eiden M; Buschmann A; Groschup MH
    Biochim Biophys Acta; 2007 Jun; 1772(6):704-13. PubMed ID: 17145171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Unexposed Secrets of Prion Protein Oligomers.
    Wang G; Wang M; Li C
    J Mol Neurosci; 2015 Aug; 56(4):932-937. PubMed ID: 25823438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective and neurotoxic signaling by the prion protein.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Top Curr Chem; 2011; 305():101-19. PubMed ID: 21598098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl.
    Behrens A; Aguzzi A
    Trends Neurosci; 2002 Mar; 25(3):150-4. PubMed ID: 11852147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.